Keywords
How to Cite
Abstract
Disorders in the fetoplacental complex of pregnant women with chronic respiratory diseases (CRD) is one of the actual problems of modern obstetrics in medical, economic and social aspects. Respiratory diseases in the context of disorders of the fetoplacental complex (FPC) may be a comorbid process, a background to the pathology of pregnancy, or a premorbid condition that contributes to the development of placental dysfunction (PD) or even initiates it; morphophysiological changes characteristic of pregnancy also affect the state of the respiratory system, moderating the course of bronchoobstructive pathology. The presence of respiratory diseases in women, the impact of its treatment and features of the course and medical support of pregnancy in these conditions affect the condition of both the woman and the fetus, and in the future - the physical and neuropsychological development of the child.
References
Ali S. M., Khalil R. A. Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy. Expert Opin Ther Targets. 2015. Vol. 19, No.11. P. 1495-1515.
Baghlaf H., Spence A. R., Czuzoj-Shulman N. [et al.]. Pregnancy outcomes among women with asthma. J Matern Fetal Neonatal Med. 2019. Vol. 32, No.8. P. 1325-1331.
Shaked E., Wainstock T., Sheiner E. [et al.]. Maternal asthma: pregnancy course and outcome. J Matern Fetal Neonatal Med. 2019. Vol. 32, No.1. P. 103-108.
Shaheen S. O., Lundholm C., Brew B. K. [et al.]. Prescribed analgesics in pregnancy and risk of childhood asthma. Eur Respir J. 2019. Vol. 53, No.5. P. 1801090.
Healthcare costs of asthma comorbidities: a systematic review protocol. Ferkh K. E., Nwaru B. I., Griffiths C. [et al.]. BMJ Open. 2017. Vol. 7, No.5. P. e015102.
Mathad J. S., Gupta A. Pulmonary Infections in Pregnancy. Semin Respir Crit Care Med. 2017. Vol. 38, No.2. P. 174-184.
Mehta N., Chen K., Hardy E. [et al.]. Respiratory disease in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2015. Vol. 29, No.5. P. 598-611.
McDonald C. R., Darling A. M., Liu E. [et al.]. Angiogenic proteins, placental weight and perinatal outcomes among pregnant women in Tanzania. PLoS One. 2016. Vol. 11, No.12. P. e0167716.
Seeni I., Ha S., Nobles C. [et al.]. Air pollution exposure during pregnancy: maternal asthma and neonatal respiratory outcome. Ann Epidemiol. 2018. Vol. 28, No.9. P. 612-618. e4.
Pereira de Jesus S. M. C., den Dekker H. T., de Jongste J. C. [et al.]. Maternal hemoglobin and hematocrit levels during pregnancy and childhood lung function and asthma. The Generation R Study. Pediatr Pulmonol. 2018. Vol. 53, No.2. P. 130-137.
Garne E., Vinkel Hansen A., Morris J. [et al.]. Risk of congenital anomalies after exposure to asthma medica-tion in the first trimester of pregnancy ‒ a cohort linkage study. BJOG. 2016. Vol. 123, No.10. P. 1609-1618.
Ali Z. Asthma and Pregnancy: Possible to prevent complications? With Special reference to the impact of obesity and type of airwayinflammation. Dan Med J. 2017. Vol. 64, No.12. P. B5428.
Rocklin R. E. Asthma, asthma medications and their effects on maternal/fetal outcomes during pregnancy. Reprod Toxicol. 2011. Vol. 32, No.2. P. 189-197.
Zhong N., Lin J., Zheng J. [et al.]. Uncontrolled asthma and its risk factors in adult Chinese asthma patients. Ther Adv Respir Dis. 2016. Vol. 10, No.6. P. 507-517.
Tamási L., Horváth I., Bohács A. [et al.]. Asthma in pregnancy ‒ immunological changes and clinical man-agement. Respir Med. 2011. Vol. 105, No. 2. P. 159-164.
Bulut I., Ozseker Z. F., Coskun A. [et al.]. Pregnancy-associated plasma protein-A (PAPP-A) levels in pa-tients with severe allergic asthma are reduced by omalizumab. J Asthma. 2018. Vol. 55, No.10. P. 1116-1121.
Rejnö G., Lundholm C., Gong T. [et al.]. Asthma during pregnancy in a population-based study ‒ pregnancy complications and adverse perinatal outcomes. PLoS One. 2014. Vol. 9, No.8. P. e104755.
Forinash A. B., Chamness D., Yancey A. M. [et al.]. Impact of Clinical Pharmacy on Asthma in Pregnancy in a Maternal-Fetal Care Clinic. J Pharm Technol. 2016. Vol. 32, No.6. P. 240-244.
Wan T., Skeith L., Karovitch A. [et al.]. Guidance for the diagnosis of pulmonary embolism during pregnan-cy: Consensus and controversies. Thromb Res. 2017. No.157. P. 23-28.
Meakin A. S., Saif Z., Jones A. R. [et al.]. Review: Placental adaptations to the presence of maternal asthma during pregnancy. Placenta. 2017. No.54. P. 17-23.
Alqalyoobi S., Zeki A. A., Louie S. Asthma Control During Pregnancy: Avoiding Frequent Pitfalls. Con-sultant. 2017. Vol. 57, No.11. P. 662-665.
Charlton R. A., Hutchison A., Davis K. J. [et al.]. Asthma management in pregnancy. PLoS One. 2013. Vol. 8, No.4. P. e60247.
Lin S., Munsie J. P., Herdt-Losavio M. L. [et al.]. Maternal asthma medication use and the risk of selected birth defects. Pediatrics. 2012. Vol. 129, No.2. P. e317-324.
Lin S., Munsie J. P., Herdt-Losavio M. L. [et al.]. Maternal asthma medication use and the risk of selected birth defects. Pediatrics. 2012. Vol. 129, No.2. P. e317-324.
Turkeltaub C., Cheon J., Friedmann E. [et al.]. The Influence of Asthma and/or Hay Fever on Pregnancy: Data from the 1995 National Survey of Family Growth. P J Allergy Clin Immunol Pract. 2017. Vol. 5, No.6. P. 1679-1690.
Giles W., Murphy V. Asthma in pregnancy: a review. Obstet Med. 2013. Vol. 6, No.2. P. 58-63.
Grosso A., Locatelli F., Gini E. [et al.]. The course of asthma during pregnancy in a recent, multicase-control study on respiratory health. Allergy Asthma Clin Immunol. 2018 No.14. P. 16.
Clifton V. L., Engel P., Smith R. [et al.]. Maternal and neonatal outcomes of pregnancies complicated by asthma in an Australian population. Aust N Z J Obstet Gynaecol. 2009. Vol. 49, No.6. P. 619-626.
Almeida M. L., Santana P. A., Guimarães A. M. [et al.]. Asthma and pregnancy: repercussions for neonates. J Bras Pneumol. 2010. Vol. 36, No.3. P. 293-300.
Fildan, A.P., Bratila, E., Tofolean, D., Tudorache, E., Dantes, E. Asthma and pregnancy. Ginecol. 2016. Vol. 12. No.2. P. 91-94.
Robijn A. L., Murphy V. E., Gibson P. G. Recent developments in asthma in pregnancy. Curr Opin Pulm Med. 2019. Vol. 25, No.1. P. 11-17.
Kelly W., Massoumi A., Lazarus A., Postgrad A. Asthma in pregnancy: Physiology, diagnosis, and manage-ment. Med. 2015. Vol. 127, No.4. P. 349-358.
Desalu O. O., Adesina K. T., Ojuawo O. B., Ogunlaja I. P., Alaofin W. A., Aladesanmi A. O. [et al.]. Preva-lence of asthma and respiratory symptoms during pregnancy in the middle belt of Nigeria. Journal of Asthma. 2019. 2-s2.0-85065018673.
Ali Z., Nilas L., Ulrik C. S. Excessive gestational weight gain in first trimester is a risk factor for exacerba-tion of asthma during pregnancy: A prospective study of 1283 pregnancies. J Allergy Clin Immunol. 2018. Vol. 141, No.2. P. 761-767.
Mirzakhani H., Carey V. J., McElrath T. F. [et al.]. The Association of Maternal Asthma and Early Pregnancy Vitamin D with Risk of Preeclampsia: An Observation From Vitamin D Antenatal Asthma Reduction Trial (VDAART). J Allergy Clin Immunol Pract. 2018. Vol. 6, No.2. P. 600-608. e2.
Romanyuk V., Raichel L., Sergienko R. [et al.]. Pneumonia during pregnancy: radiological characteristics, predisposing factors and pregnancy outcomes. J Matern Fetal Neonatal Med. 2011. Vol. 24, No.1. P. 113-117.
Harju M., Pekkanen J., Heinen S. [et al.]. Maternal anemia during pregnancy and slightly higher risk of asth-ma in male offspring. J Obstet Gynaecol Res. 2018. Vol. 44, No.4. P. 614-622.
Herraiz I., Simón E., Gómez-Arriaga P. I. [et al.]. Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical Integration. Int J Mol Sci. 2015. Vol. 16, No.8. P. 19009-19026.
Latendresse G., Founds S. The Fascinating and Complex Role of the Placenta in Pregnancy and Fetal Well-being. J Midwifery Womens Health. 2015. Vol. 60, No.4. P. 360-370.
Song H., Yang L., Jia C. Maternal vitamin D status during pregnancy and risk of childhood asthma: A meta-analysis of prospective studies. Mol Nutr Food Res. 2017. Vol. 61, No. 5. DOI: 10.1002/mnfr.201600657.
Ali S. M., Khalil R. A. Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy. Expert Opin Ther Targets. 2015. Vol. 19, No.11. P. 1495-1515.
Viljoen K., Segurado R., O'Brien J. [et al.]. Pregnancy diet and offspring asthma risk over a 10-year period: the Lifeways Cross Generation Cohort Study, Ireland. BMJ Open. 2018. Vol. 8, No.2. P. e017013.
Lazurenko V. V., Bilyi Ye. Ye. Fetoplacental complex violations in pregnant women with bronchial asthma. Proceedings of the Fifth International Conference of European Academy of Science. February 20–28, 2019. P. 28–29.
Frolova T. V., Lazurenko V. V., Pasiyeshvili N. M. [et al.]. Placental Dysfunction: health status, nutritional status and mineral profile of a mother-child pair. Wiadomosci lekarskie. 2020. Vol. 73, No.1. P. 95–98.
"Inter Collegas" is an open access journal: all articles are published in open access without an embargo period, under the terms of the CC BY-NC-SA (Creative Commons Attribution ‒ Noncommercial ‒ Share Alike) license; the content is available to all readers without registration from the moment of its publication. Electronic copies of the archive of journals are placed in the repositories of the KhNMU and V.I. Vernadsky National Library of Ukraine.
Copyright Agreement
1. This Agreement on the transfer of rights to use the work from the Co-authors to the publisher (hereinafter the Agreement) is concluded between all the Co-authors of the work, represented by the Corresponding Author, and Kharkiv National Medical University (hereinafter the University), represented by an authorized representative of the Editorial Board of scientific journals (hereinafter the Editorial Board).
2. This Agreement is an accession agreement within the meaning of clause 1 of Article 634 of the Civil Code of Ukraine: that is, a contract, "the terms of which are established by one of the parties in forms or other standard forms, which can be concluded only by joining the other party to the proposed contract as a whole. The other party cannot offer its terms of the contract." The party that established the terms of this contract is the University.
3. If there is more than one author, the authors choose the Corresponding Author, who communicates with the Editorial Board on his own behalf and on behalf of all Co-authors regarding the publication of a written work of a scientific nature (article or review, hereinafter referred to as the Work).
4. The contract begins from the moment of submission of the manuscript of the Work by the Corresponding Author to the Editorial Board, which confirms the following:
4.1. all Co-authors of the Work are familiar with and agree with its content, at all stages of reviewing and editing the manuscript and the existence of the published Work;
4.2. all Co-authors of the Work are familiar with and agree to the terms of this Agreement.
5. The published Work is in electronic form in public access on the websites of the University and any websites and electronic databases in which the Work is posted by the University and is available to readers under the terms of the "Creative Commons" license (Attribution NonCommercial Sharealike 4.0 International)" or more free licenses "Creative Commons 4.0".
6. The Corresponding Author transfers, and the University receives, the non-exclusive property right to use the Work by placing the latter on the University's websites for the entire term of copyright. The University participates in the creation of the final version of the Work by reviewing and editing the manuscript of the article or review provided to the Editorial Board by the Corresponding Author, translating the Work into any languages. For the participation of the University in the finalization of the Work, the Co-authors agree to pay the invoice issued to them by the University, if such payment is provided by the University. The size and procedure of such payment are not the subject of this contract.
7. The University has the right to reproduce the Work or its parts in electronic and printed forms, to make copies, permanent archival storage of the Work, distribution of the Work on the Internet, repositories, scientometric databases, commercial networks, including for monetary compensation from third parties.
8. The co-authors guarantee that the manuscript of the Work does not use works whose copyright belongs to third parties.
9. The authors of the Work guarantee that at the time of submission of the manuscript of the Work to the Editorial Board, the property rights to the Work belong only to them, neither in whole nor in part have they been transferred to anyone (not alienated), they are not the subject of a lien, litigation or claims by third parties.
10. The Work may not be posted on the University's website if it violates a person's right to the privacy of his personal and family life, harms public order and health.
11. The work may be withdrawn by the Editorial Board from the University websites, libraries and electronic databases where it was placed by the Editorial Board, in cases of detection of violations of the ethics of the authors and researchers, without any compensation for the losses of the Co-authors. At the time of submission of the manuscript to the Editorial Board and all stages of its editing and review, the manuscript must not have already been published or submitted to other editorial offices.
12. The right transferred under this Agreement extends to the territory of Ukraine and foreign countries.
13. The rights of Co-authors include the requirement to indicate their names on all copies of the Work or during any public use or public mention of the Work; the requirement to preserve the integrity of the Work; legal opposition to any distortion or other encroachment on the Work, which may harm the honor and reputation of the Co-authors.
14. Co-authors have the right to control their personal non-property rights by familiarizing themselves with the text (content) and form of the Work before its publication on the University's website, when transferring it to a printing company for reproduction or when using the Work in other ways.
15. The Co-authors, in addition to the property rights not transferred under this Agreement and taking into account the non-exclusive nature of the rights transferred under this Agreement, retain the property rights to finalize the Work and to use certain parts of the Work in other works created by the Co-authors.
16. The Co-authors are obliged to notify the Editorial Board of all errors in the Work, discovered by them independently after the publication of the Work, and to take all measures to eliminate such errors as soon as possible.
17. The University undertakes to indicate the names of the Co-authors on all copies of the Work during any public use of the Work. The list of Co-authors may be shortened according to the rules for the formation of bibliographic descriptions determined by the University or third parties.
18. The University undertakes not to violate the integrity of the Work, to agree with the Corresponding Author on all changes made to the Work during processing and editing.
19. In case of violation of their obligations under this Agreement, its parties bear the responsibility defined by this Agreement and the current legislation of Ukraine. All disputes under the Agreement are resolved through negotiations, and if the negotiations do not resolve the dispute – in the courts of the city of Kharkiv.
20. The parties are not responsible for the violation of their obligations under this Agreement, if it occurred through no fault of theirs. The party is considered innocent if it proves that it has taken all measures dependent on it for the proper fulfillment of the obligation.
21. The Co-authors are responsible for the truthfulness of the facts, quotes, references to legislative and regulatory acts, other official documentation, the scientific validity of the Work, all types of responsibility to third parties who have claimed their rights to the Work. The co-authors reimburse the University for all costs caused by claims of third parties for infringement of copyright and other rights to the Work, as well as additional material costs related to the elimination of identified defects.